Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)
|ClinicalTrials.gov Identifier: NCT01073592|
Recruitment Status : Completed
First Posted : February 23, 2010
Last Update Posted : May 17, 2013
The Foresee Home is used in the recent years to detect age-related macular degeneration (AMD) lesions. The device is capable of differentiation as to stages of AMD and early detection of changes including choroidal neovascularization (CNV). The Foresee Home demonstrates a high level of sensitivity and specificity as to the different stages of AMD including newly diagnosed or early detection of CNV.
The OCT may be use as well to identify choroidal neovascularization (CNV). Comparison between the two methods will allow better understanding of both devices.
The Foresee Home can use as an assessment tool for the progression and success of the treatment given to AMD lesions. Therefore, evaluation the size and the location of the treated lesions may serve as an additional tool.
|Condition or disease|
|Age Related Macular Degeneration|
|Study Type :||Observational|
|Actual Enrollment :||10 participants|
|Official Title:||Comparison Between Home Macular Perimeter (FORESEE HOME) and OCT Visual Field Defects in Patients With CNV|
|Study Start Date :||August 2009|
|Primary Completion Date :||January 2013|
|Study Completion Date :||March 2013|
- Size and location of lesions [ Time Frame: 6 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01073592
|Rabin Medical Center|
|Petach Tikva, Israel|
|Principal Investigator:||Ruth Siegal, Prof.||Rabin Medical Center|